ImmunityBio, Inc.IBRXNASDAQ
Loading
Asset Growth Under PressureDecelerating
Percentile Rank59
Studio
Year-over-Year Change

Year-over-year total asset growth rate

Percentile
P59
Within normal range
vs 5Y Ago
0x
Contraction
Streak
2 qtr
Consecutive declineDecelerating
PeriodValue
Q4 2025-3.29%
Q3 202529.08%
Q2 202532.37%
Q1 2025-20.68%
Q4 20245.04%
Q3 2024-17.95%
Q2 202410.89%
Q1 2024-20.57%
Q4 202316.66%
Q3 202348.48%
Q2 2023-15.19%
Q1 2023-5.23%
Q4 20222.67%
Q3 202211.09%
Q2 2022-18.45%
Q1 2022-16.92%
Q4 2021118.69%
Q3 2021-12.94%
Q2 202117.61%
Q1 2021-5.40%
Q4 202089.43%
Q3 2020-40.42%
Q2 202054.43%
Q1 2020-11.25%
Q4 2019-10.66%
Q3 2019-8.82%
Q2 2019-15.64%
Q1 201914.46%
Q4 2018-9.77%
Q3 2018-4.63%
Q2 2018-8.01%
Q1 2018-8.22%
Q4 2017-9.83%
Q3 2017-7.92%
Q2 2017-0.68%
Q1 2017-4.35%
Q4 2016-4.49%
Q3 2016-3.07%
Q2 2016-4.05%
Q1 2016-2.57%